Cartesian Therapeutics, Inc.
NASDAQ:RNAC · NASDAQ Global Market
-$0.41 today
Vol 0.35M · Avg 0.26M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-2.03%
Period High
$13.77
Period Low
$5.84
Latest
$9.63
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Genfit S.A.
GNFT
$445.68M
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$282.12M
Fennec Pharmaceuticals Inc.
NASDAQ:FENC
$254.36M
Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
$234.13M
Eupraxia Pharmaceuticals Inc.
NASDAQ:EPRX
$214.67M
Inventiva S.A.
NASDAQ:IVA
$184.02M
Avalo Therapeutics, Inc.
NASDAQ:AVTX
$169.41M
MediWound Ltd.
NASDAQ:MDWD
$153.32M
Neonc Technologies Holdings, Inc.
NASDAQ:NTHI
$100.17M
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
$85.85M
What is the latest RNAC filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does RNAC have?
Intrinsic Alpha currently shows 20 recent filings for RNAC.
Explore More
Continue the stock analysis
Jump to another research area for this company.